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Purpose: Although some studies have suggested an association between cardiovascular 
disease and restless legs syndrome (RLS), the mechanisms underlying this relationship 
remain unclear. The intima-media thickness (IMT) and vasomotor reactivity are two simple, 
non-invasive tools to investigate preclinical atherosclerosis and microangiopathy, respec-
tively. The aims of this study were to evaluate carotid IMT and to explore vasomotor 
reactivity in idiopathic RLS (iRLS) patients.
Patients and Methods: We enrolled 44 iRLS after exclusion of patients with secondary 
causes of RLS, history of vascular events, known uncontrolled vascular risk factors and other 
neurological disorders. Forty-four age and sex matched controls were therefore recruited. No 
significant differences in demographic data and vascular risk factors were found between the 
two groups. Carotid IMT was measured with a high-resolution B-mode ultrasound on the far- 
wall of common carotid artery, 10 mm and 30 mm to the carotid bulb. Vasomotor reactivity 
to hypo- and hypercapnia was assessed, by right middle cerebral artery transcranial Doppler, 
accordingly to the changes in peak systolic velocity, peak diastolic velocity and mean blood 
flow velocity.
Results: Mean IMT was significantly increased in patients with iRLS when measured 
immediately proximally to carotid bifurcation (0.73; sd=0.17), versus controls (0.65; 
sd=0.13); p=0.035. Patients showed higher cerebrovascular flow velocities (CBFVs) com-
pared to controls. After multivariate analysis, age, hypertension and iRLS proved to be 
independent IMT predictors.
Conclusion: Increased IMT and higher CBFVs in iRLS support the association of iRLS 
with vascular damage, possibly through enhanced atherogenesis and sympathetic hyperac-
tivity. However, to clarify a causal relationship, further longitudinal assessment of these 
parameters is needed, trying to control all their physiological modifying factors.
Keywords: atherosclerosis, carotid disease, stroke, sleep disorders
Introduction
Restless legs syndrome (RLS) is a common neurological sensory-motor disorder 
characterized by an uncontrollable urge to move legs, often accompanied by 
sensory discomfort. Other features include worsening of symptoms at night or 
with inactivity and development of relief with movement.1 RLS can be primary, 
idiopathic (iRLS), or secondary to anemia, low iron levels, kidney failure, periph-
eral neuropathy, drugs, etc.2 Moreover, few studies showed that stroke as well, 
notably with a subcortical or brainstem location, is responsible for secondary forms 
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of RLS.3,4 Several data suggest a very complex pathoge-
netic interplay among multi-transmitter neurochemical 
pathways in RLS. Their dysfunction seems to be deter-
mined both by genetic and acquired factors.5 This multi-
faceted background probably justify the conflicting and 
often inconsistent evidence on the association between 
RLS and cardio-vascular disease (CVD). However, this 
might also be the consequence of the limited number of 
papers on this topic and the difficulty to exclude frequent 
comorbid conditions such as hypertension and other vas-
cular risk factors, obstructive sleep apnea, etc.6,7 Different 
possible mechanisms have been postulated linking RLS to 
the development of CVD. The direct enhancement of 
atherogenesis is the least likely. The sympathetic over 
activity, in association with hypertension, seems to be the 
direct pivotal factor in determining vessels damage. It is 
still debated which of these two elements actually start the 
pathological cascade, but their relationship seems bidirec-
tional once established.
IMT provides a surrogate marker of cardiovascular 
outcomes in clinical trials evaluating the efficacy of cardi-
ovascular risk factors modification. Many studies have 
successfully applied IMT as a technique to monitor arterial 
wall alterations based upon its association with cardiovas-
cular risk factors and incident cardiovascular disease. 
Moreover, increased carotid IMT is a non-invasive marker 
of systemic atherosclerosis and is related to the risk of 
future CVD and stroke.8–10
Cerebrovascular Vasomotor Reactivity is defined as 
the percent change in blood flow velocity in response to 
changes in carbon dioxide, which can act as a powerful 
vasodilator.11,12 Clinically, CVR can be assessed by 
Transcranial Doppler (TCD) and can be tested by hold- 
breathing and hyperventilation tests, measuring the abil-
ity of the cerebral micro-vessels to dilate and constrict in 
response to hypercapnia and hypocapnia. Therefore, CVR 
gives an index of reactivity of the intracranial vessels in 
response to a stimulus through ventilatory alterations of 
PaCO2.13 Impairment of CVR has been linked to pathol-
ogies as obstructive and central sleep apnea,14–16 carotid 
artery stenosis,17 hypertension,18 congestive heart 
failure19 and cerebral ischemic events.20 Moreover, it 
proved to be an independent predictor of ischemic stroke 
in some studies.21–23 However, all those studies show 
some conflicting pathophysiological interpretations, 
probably due to the complexity of physiological 
responses and to the presence of several modifying 
factors.
The aim of our study was to investigate the relationship 
between iRLS and vascular diseases, through the analysis 
of two parameters: IMT, as a non-invasive marker of 
systemic atherosclerosis; CVR (through analysis of cere-
bral blood flow velocity; CBFV), to identify a hypothetical 
impairment in vascular function and changes in autonomic 
system. The need to study this relationship rise because 
even if there is an increasing amount of evidence support-
ing the association between RLS and vascular diseases, the 
mechanisms underlying this relationship still remain 
unclear: whether it enhances atherosclerosis or impairs 
vascular response, which eventually leads to higher sus-
ceptibility to vascular risk factors themselves.
Materials and Methods
Participants’ Selection
A screening of patients available on the University of 
Udine Neurology Unit database, presenting to the “Sleep 
Disorders” outpatient service or admitted as inpatients, 
between January 2011 and December 2013, was per-
formed before study enrolment. Participants were then 
evaluated from June 2014 to April 2016. We included in 
the study people affected by idiopathic RLS according to 
international criteria,1 aged over 18 years.
Using clinical and laboratory data, we excluded from 
the patients group, people with iron deficiency, renal fail-
ure, pregnancy, history of vascular diseases (stroke, tran-
sient ischemic attack, acute myocardial infarction, angina 
pectoris, history of percutaneous transluminal coronary 
angioplasty, claudicatio intermittens), untreated and 
uncontrolled high blood pressure, patients with poor gly-
cemic control, smoking >20 cigarettes per day, with car-
otid plaques, with features of cerebral small vessel disease 
(as detected by brain structural imaging). Patients with 
other known neurological disorders, arising from clinical 
history or suspected after examination, were also 
excluded.
Clinical history was used to exclude from control 
group people with anemia, renal failure, pregnancy, vas-
cular diseases, risk factors and other neurological diseases 
(as already specified above for patients’ group).
Group size was determined according to the number of 
patients evaluated during two years in our sleep-disorders 
outpatient service. Patients were classified by sex and by 
age, with assignment to 5-years-age intervals; controls 
were then selected, without RLS and according to exclu-
sion criteria, among the sanitary personnel of our 
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department and their relatives, trying to correspond to 
patients’ distribution.
All participants were evaluated according to the same 
protocol and provided written informed consent. The study 
was considered exempt from “Institutional Review Board” 
(IRB) approval because collected information consisted only 
in: i. a more detailed medical history than the usual one in an 
outpatient visit; ii. blood tests that patients with RLS do as 
standard diagnostic workup; iii. non-invasive echographic 
imaging. The study was conducted in accordance with the 
ethical principles for medical research involving human 
subjects stated in the Declaration of Helsinki.
Variables Collected
Participants’ demographics, information about smoke, 
alcohol and coffee consumption habits, current treatments 
(antidepressants, dopaminergic drugs, anti-epileptics, ben-
zodiazepines, etc.) comorbidity, laboratory data and vas-
cular risk factors were collected during a face-to-face 
interview, conducted by a physician expert in Sleep 
Medicine. Furthermore, data concerning sleep quality 
(Epworth Sleep Scale and Pittsburgh Sleep Scale), 
obstructive sleep apnea syndrome (OSAS) risk (Berlin 
Questionnaire and polysomnographic study of participants 
at risk) and RLS features (clinical criteria, RLS Severity 
Scale, history of familial RLS, onset, distribution and 
severity of symptoms, etc.) were obtained.
We calculated the body mass index by checking their 
body weight and their height. Hypertension was defined as 
a systolic blood pressure > or = 140 mmHg and/or diasto-
lic blood pressure > or = 90 mmHg, or as a report of 
current treatment with anti-hypertensives. Diagnosis of 
diabetes mellitus was considered according to ADA stan-
dard criteria and in case of treatment with anti-diabetic 
drugs. Hypercholesterolemia was defined as total serum 
cholesterol > or = 230 mg/dl or current treatment with 
cholesterol-lowering drugs. Positivity to “Thyroid disease” 
refers to both hypothyroidism and hyperthyroidism or 
normal thyroid function with medications. A plaque was 
defined as a focal structure that encroached into the arterial 
lumen at least 0.5 mm or that was 50% of the surrounding 
IMT value, or that had a thickness >1.5 mm as measured 
from the media-adventitia interface to the intima-lumen 
interface.
Carotid IMT Measurements
Measurement of carotid intima-media thickness (IMT) was 
performed by high-resolution B-mode ultrasonography 
(Toshiba Aplio 400), using a 7 MHz linear ultrasound 
transducer, according to the guidelines of the Mannheim 
IMT Consensus.24 The IMT was defined as the distance 
from the leading edge of the lumen-intima interface to the 
leading edge of the media-adventitia interface of the far 
wall.25 A longitudinal image of the common carotid artery 
(CCA), strictly perpendicular to the ultrasound beam, was 
obtained proximally to the carotid bulb, with the patient in 
a supine position. After clearly identifying the double-line 
pattern, we proceed to measure the CCA-IMT on the far 
wall of the left and of the right side, using a range- 
calibrated trackball, approximately 10 mm and 30 mm to 
the carotid bulb. An automated system (USAI-790A/EL 
Auto IMT – Toshiba Medical System©) provided the 
measurement of mean IMT on both sides. Moreover, auto-
mated system could provide the mean maximum value of 
100 measurements performed on a 5-mm segment of CCA 
instantaneously. Figure 1 shows an example of measure-
ment methodology. All these and the following sono-
graphic measurements were carried out by an 
experienced neurosonologist, blinded to the subjects’ 
group assignment.
Transcranial Doppler Assessment
Vasomotor reactivity was measured as follows. Participants 
laid in supine position and were asked to breathe normally 
for 1 minute; the proximal part of the right middle cerebral 
artery (MCA) was then insonated through trans-temporal 
approach with a 2 MHz probe at a 5 to 6 cm depth and the 
Doppler signal was optimized by adjusting probe position 
precisely. Examinations were performed by a single experi-
enced neurosonologist. Peak systolic velocity, end diastolic 
velocity and mean blood flow velocity were evaluated at 
rest (as baseline), after 30-seconds or maximum-tolerated 
Figure 1 Intima media thickness. 
Notes: Here is reported a picture of an IMT measurement. In this example, the 
IMT has been measured at 1 cm from carotid bifurcation, along the carotid far- 
walland within a 1cm width RoI. 
Abbreviations: IMT, Intima Media Thickness; RoI, Region of Interest.
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breath-holding (after a normal inspiration to avoid 
a Valsalva manoeuvre) and during hyperventilation (when 
stable flow was obtained). Flow Velocity Excursion (F.V.E.) 
was defined as the difference between baseline values and 
post-manoeuvre values. We chose to record right MCA only 
according to published evidence of substantial equivalence 
between the two sides.26 People with absent or suboptimal 
acoustic window were not included in the analysis.
Statistical Analysis
A power analysis was not performed. Demographic and 
clinical data are presented as mean ± sd or as absolute 
number (and percentage out of total) according to the 
nature of the variable itself. In the univariate analysis 
a Student’s t-test for independent samples was used for 
normally distributed continuous variables; a chi-square test 
was used for categorical variables. A p-value <0.05 was 
considered as limit of significance for both tests. 
A multiple-regression model was used to explore the inter-
play among different variables in predicting IMT value. 
Analysis was performed using SPSS 13.0.
Results
From June 2014 to April 2016, we enrolled 48 consecutive 
patients with iRLS; 4 patients were excluded after enrol-
ment because of emerging exclusion criteria (1 for evi-
dence of carotid plaque; 1 for a history of a possible TIA; 
2 due to missing of a reliable medical history) and 44 
patients were finally included in the analysis and compared 
to 44 controls. Clinical and anthropometric characteristics 
of all the participants are shown in Table 1. No significant 
differences in demographic and vascular risk factors data 
were found between patients with iRLS and controls. The 
mean age was 57.6 ± 12.6 years in the iRLS group and 
56.5 ± 11.7 years in the control group. Thirty women were 
enrolled in the iRLS group (54.5%) and 25 women were 
selected in the control group (45.5%). A mean BMI of 
26.0 ± 4.1 was measured in iRLS group and a mean BMI 
of 24.7 ± 2.8 in the control group; the difference in BMI, 
though not significant (p = 0.09), is mainly due to 6 
patients with a BMI > 30 in the iRLS group; on the 
contrary, no one in the control group had a BMI > or = 30.
Table 2 shows IMT values: we found significant 
difference between the two group in mean and maxi-
mum IMT when measured proximally (at 1 cm) to 
carotid bifurcation, while no significant difference was 
observed in mean and maximum IMT values at 3 cm far 
from carotid bifurcation. We found a strong correlation 
between age and mean IMT values (r = 0.65; p<0.001 
among all participants and r = 0.77; p <0.001 consider-
ing patients with iRLS only). A significant correlation is 
present as well between RLS duration (years from 
onset) and mean IMT values (r = 0.35; p = 0.02). If 
a “lifetime exposure” to RLS was calculated (as a ratio 
between years from RLS onset and age) this variable 
was not significantly associated with mean IMT values 
(r = 0.18; p = 0.28). These results are shown in 
Figure 2. Similar results are also provided in the same 
figure for maximum IMT. RLS severity was not corre-
lated with mean IMT (r = 0.56; p = 0.72).






t-test (95% C.I.) or X2
Age, mean (sd) 57.6 (12.6) 56.5 (11.7) 0.69
Sex, n-female (%) 30/44 (54.5) 25/44 (45.5) 0.38
BMI, mean (sd) 26.0 (4.1) 24.7 (2.8) 0.09
Smoke n(%) 12/44 (27.3) 15/44 (34.1) 0.64
Alcohol n(%) 14/44 (31.8) 16/43 (37.2) 0.66
Coffee n(%) 38/44 (86.4) 34/44 (77.3) 0.47
Thyroid disease 8/44 (18.2) 6/44 (13.6) 0.77
Hypercholesterolemia 7/44 (15.9) 8/43 (18.6) 0.78
Hypertension 13/44 (29.5) 7/43 (16.3) 0.20
OSAS 10/44 (22.7) 8/44 (18.2) 0.79
RLS – severity scale 21.8 (6.0) - -
RLS – years from onset median (min-max) 5 (1–45) - -
Dopaminergic treatment n(%)* 30/44 (68.2) 0/44 -
Note: *The % here reported refers to the proportion of patients treated at the time of study evaluation. 
Abbreviations: BMI, Body Mass Index; OSAS, Obstructive Sleep Apnea Syndrome.
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We tested in a multiple-regression model the role of 
Age, BMI, Hypertension, OSAS and diagnosis of iRLS as 
predictors of mean-IMT increase (Table 3): in this model 
Age is the strongest predictor, RLS is still significantly 
associated to IMT levels and hypertension is marginally 
significant.
Nine subjects with a poor acoustic window, 4 in the 
iRLS group and 5 in the control group, were excluded 
from TCD assessment. Table 4 shows mean and maximum 
middle cerebral artery (MCA) velocities at basal condi-
tions, after breath-holding test and during hyperpnoea in 
the two groups. A statistically significant difference 
between the two groups was found in all the three settings. 
Overall blood Flow Velocity Excursion (F.V.E.) is signifi-
cantly increased in patients versus controls (mean F.V.E. = 
30.3 ±12.8 cm/s versus 15.0 ± 12.5 cm/s), mainly due to 
a different pattern of flow velocity change in hold-breath 
test between patients (mean F.V.E. = 12.1 ± 10.2) and 
controls (mean F.V.E. = −2.3 ± 12.4).
Discussion
In this study, we found that IMT, measured proximally to 
carotid bifurcation (1 cm), is increased in iRLS patients, 
compared to age- and sex-matched controls; we also found 
that age, RLS and hypertension were independent IMT 
predictors after multivariate analysis. According to our 
data, no statistically significant differences in IMT at 
3 cm from carotid bifurcation have been observed. 
Compared to IMT values at 1 cm from carotid bifurcation, 
measurement at 3 cm could be less exposed to low shear- 
stress and blood pressure damage, as suggested by few 
studies.27 Our results appear to be consistent with other 
studies on RLS supporting a strict association between 
CVD and iRLS, in particular when associated with iso-
lated periodic limb movements (PLMs), brief muscle acti-
vations occurring at regular intervals.6 Nevertheless, our 
results do not confirm data published in 2012 by Park,28 
which showed a maximum value of IMT in patients with 
iRLS lower than in controls, after adjustment for vascular 
risk factors. In Park’s paper, patients with RLS and PLMs 
were excluded. On our hand, we did not systematically 
investigate the presence of PLMs with laboratory poly-
somnography (PSG) in all participants. However: i) PMLs 
are extremely common in patients with RLS, up to 90% of 
cases;29 ii) They are not specific for a diagnosis of RLS 
(being associated with post-traumatic stress disorder, nar-
colepsy, renal disease, congestive heart failure, alcoholism, 
mood disorders, Parkinson’s disease, idiopathic REM 
sleep behavior disorder, diabetes mellitus, normal aging, 
etc.) iii) To exclude PLMs in iRLS is difficult with a single 
recording. Given these considerations, we think it would 
be much more informative to correlate PLMs frequency in 
PSG to IMT or other variables, rather than including only 
iRLS presumed to be negative for PLMs.
It is likely that the slightly more elevated BMI in the 
iRLS group (6 patients with BMI > or = 30), not statisti-
cally significant, should not have contributed importantly 
to determine a significant difference between cases and 
controls IMTs. In fact, although BMI positively correlates 
with IMT (r = 0.28; p = 0.01), it was not an independent 
predictor of IMT value in the multiple regression model. 
Compared with Park study, we have tried to better char-
acterize RLS in patients, recording severity and disease 
burden (in years from onset to evaluation). A significant 
correlation is present between RLS duration (years from 
onset) and IMT values, but If a “lifetime exposure” to RLS 
was calculated (as shown in Figure 2) this variable is not 
significantly associated with IMT values. This result seems 
to be affected by the strong correlation between age and 
IMT (Table 2). RLS severity was not significantly asso-
ciated with mean IMT. The majority of patients ranged 
between moderate and severe RLS, indicating at least 
suboptimal treatment. However, the score here reported 
refers to the time of evaluation only, thus not reflecting 
the past years trend: this might justify the apparent incon-
sistency with the other results and actually hamper spec-
ulations on the relationship between RLS severity and 
IMT. Moreover, a detailed and reliable medication history 
was lacking in the majority of our patients. This point 
precludes clear hypothesis about the consequences of 
RLS treatment (above all if effective or not) on IMT 
progression in our sample.
Altogether, the results above reported do not clarify 
a causal relationship between independent risk factors, but 
they hint at the role of hypertension and iRLS as speed-up 






t-test – 95% C.I.
Mean IMT – 1cm 0.73 (0.17) 0.65 (0.13) 0.035*
Max IMT – 1 cm 0.88 (0.20) 0.78 (0.15) 0.016*
Mean IMT – 3 cm 0.71 (0.14) 0.66 (0.10) 0.117
Max IMT – 3 cm 0.84 (0.17) 0.79 (0.13) 0.120
Notes: IMT at 1cm and 3 cm from Carotid Bifurcation respectively; *Marks 
significant p values < 0.05. 
Abbreviation: IMT, Intima Media Thickness.
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Figure 2 Intima media thickness and clinical features. 
Notes: Relationship between mean IMT (at 1cm from carotid bifurcation) and age (A), RLS duration (B) and RLS lifetime exposure (C); between max IMT (at 1cm from 
carotid bifurcation) and age (D), RLS duration (E) and RLS lifetime exposure (F) 
Abbreviations: IMT, Intima Media Thickness; RLS, Restless Legs Syndrome.
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factors on IMT increase across aging. Future studies 
should take into consideration prospectively, lifetime 
exposure to RLS, its severity and treatment.
The second aim of the study was to investigate CVR in 
patients with iRLS, supposing that cerebral microvascular 
impairment of tone adaptation in RLS could work together 
with other vascular risk factors, rather than directly enhan-
cing atherosclerotic progression. Under basal conditions, 
cerebral vessels rapidly adapt to changes in perfusion pres-
sure (cerebral autoregulation), regional metabolic require-
ments of the brain (neurovascular coupling), autonomic 
neural activity,30,31 and humoral factors (cerebrovascular 
reactivity), in particular the partial pressure of arterial car-
bon dioxide (PaCO2). Regulation of CBF is highly con-
trolled and involves a wide spectrum of regulatory 
mechanisms that together work to provide adequate oxygen 
and nutrient supply:32–38 This complex system seems to 
explain the contradictory results of some studies. Our 
research focused on CVR and shows significantly higher 
MCA velocities in iRLS compared to controls under basal 
condition, after hold-breath test and after hyperpnoea. This 
seems to be consistent with the known hypothesis that the 
loss of inhibitory function by hypothalamic dopaminergic 
neurons of the A11 area is able to shift the balance of 
descending control pathways toward excitation at the sym-
pathetic preganglionic fibers level, although some recent 
data suggest that the sympathetic system exerts its influence 
on CO2-related vasoreactivity only during hypocapnia.39 
Interestingly, the concomitant increase of CBFVs and IMT 
in our patients seems consistent with the results of other 
studies in which TCD hemodynamic changes were found in 
preclinical stages of cerebrovascular disease.40,41 This 
strengthens the hypotheses that iRLS could represent 
a facilitator of cerebrovascular damage and that it could 
increase the risk of both cerebrovascular events and vascu-
lar cognitive impairment. However, these results should be 
considered cautiously since we did not control for several 
variability factors such as concurrent medications used by 
patients and above all circadian fluctuation in CBFV. In 
fact, blood flow velocities are lower in the morning and 
higher in the afternoon and in the evening.37 We did not 
record TCD time nor plan a specific TCD time schedule. 
Moreover, hypercapnia was evaluated through maximal 
tolerated apnea, regardless of its complex-shaped response 
Table 3 Multiple Regression on Predicting Variables of Carotid 
Mean IMT
B Std. Error Beta Sig.
RLS 0.062 0.028 0.193 0.030
Age 0.007 0.001 0.545 <0.001
BMI 0.001 0.004 0.026 0.781
OSAS −0.005 0.034 −0.14 0.876
Hypertension 0.074 0.036 0.204 0.044
Constant 0.194 0.110 0.086
Abbreviations: BMI, Body Mass Index; OSAS, Obstructive Sleep Apnea 
Syndrome.
Table 4 MCA Flow Velocities by TCD





t-test – 95% C.I.
Basal Mean F.V. 53.6 (11.7) 43.9 (13.6) 0.001*
Max F.V. 79.4 (17.5) 68.6 (20.1) 0.012*
Max apnea/Hold- breathing Mean F.V. 65.7 (17.5) 41.6 (18.1) <0.001*
Max F.V. 91.9 (24.5) 63.6 (25.2) <0.001*
Hyperpnoea Mean F.V. 35.4 (9.0) 26.6 (9.8) <0.001*
Max F.V. 62.2 (15.9) 48.2 (19.6) 0.001*
Overall Excursion Mean F.V.E. 30.3 (12.8) 15.0 (11.8) <0.001*
Max F.V.E. 29.7 (15.8) 15.3 (12.5) <0.001*
Max apnea/ 
Hold- breathing
Mean F.V.E. 12.1 (10.2) −2.3 (12.4) <0.001*
Max F.V.E. 12.5 (13.6) −5.0 (14.3) <0.001*
Hyperpnoea Mean F.V.E. 18.1 (8.1) 17.4 (8.5) 0.67
Max F.V.E. 17.2 (11.0) 20.4 (8.8) 0.16
Note: *Marks significant p values < 0.05. 
Abbreviations: MCA, Middle Cerebral Artery; F.V., Flow Velocity; E., Excursion.
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which can be divided into four phases:38 differently from 
patients, in the control group mean and maximum MCA 
velocities decrease after breath-holding test compared to 
basal conditions. This might be explained by a different 
pattern of response to hypercapnia in the two groups, but 
it could also be the effect of differences in test setting 
(below, under limitations). Consequently, we can speculate 
that sympathetic hyperactivity could have determined 
higher FVs in iRLS than in controls, but we could not 
demonstrate vasoreactivity impairment in the former group.
Finally, our study has several limitations: a) The number 
of study participants was relatively small; b) No systematic 
polysomnographic data were collected in all participants to 
detect presence and number of PLMs in the two groups 
investigated; c) Electromyographic study was not system-
atically performed in RLS group to assess possible poly-
neuropathies; d) Breath-holding tests assessed by TCD 
should have taken into account time-dependent CBFV 
changes during measurement so that a “Breath-holding 
index” could have been calculated; e) Measurement of 
CBFV should be obtained at the same time during the day 
to cut out circadian rhythm variability; f) Pulsatility index 
and Resistivity index were not recorded; g) systolic and 
diastolic pressure could have been measured at the same 
time TCD was performed; h) vertebra-basilar system and 
bilateral MCA velocities were not explored; i) we also 
cannot exclude selection biases in subjects’ enrollment, in 
relation to the specific inclusion and exclusion criteria we 
chose; j) we cannot exclude the effect that drugs taken by 
patients – data not-recorded in this study – would have had 
on the neurosonologic measurements.
Due to these limitations our findings should be consid-
ered cautiously. Further studies are necessary in patients with 
iRLS to confirm them, particularly about CVR evaluation.
Conclusion
We showed that iRLS is associated with an increased IMT 
and higher CBFVs, compared to controls. The cross- 
sectional nature of this study precludes to demonstrate 
causal relationships among associated factors, but these 
results support the role of iRLS as risk cofactor for vas-
cular damage. Further longitudinal studies on CVR and 
preclinical features of vascular damage are needed to 
explore mechanisms of vascular disease in patients with 
iRLS. These studies should try to control for all its several 
physiological and pathophysiological modifying factors.
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